Hydroxychloroquine in the treatment of lichen planus-like cutaneous immune-related adverse events.
0/5 보강
APA
Mueller K, Bogner P, Kuraitis D (2025). Hydroxychloroquine in the treatment of lichen planus-like cutaneous immune-related adverse events.. JAAD case reports, 66, 144-151. https://doi.org/10.1016/j.jdcr.2025.10.002
MLA
Mueller K, et al.. "Hydroxychloroquine in the treatment of lichen planus-like cutaneous immune-related adverse events.." JAAD case reports, vol. 66, 2025, pp. 144-151.
PMID
41550314 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24).
- SLC2A1 tumour-associated macrophages spatially control CD8 T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.
- Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
- Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy.
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.